BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2112489)

  • 21. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen and progesterone receptor content of GnRH analogue pretreated and untreated uterine leiomyomata.
    Regidor PA; Schmidt M; Callies R; Kato K; Schindler AE
    Eur J Obstet Gynecol Reprod Biol; 1995 Nov; 63(1):69-73. PubMed ID: 8674569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.
    Severino MF; Murray MJ; Brandon DD; Clinton GM; Burry KA; Novy MJ
    Mol Hum Reprod; 1996 Nov; 2(11):823-8. PubMed ID: 9237221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
    Malik M; Britten J; Cox J; Patel A; Catherino WH
    Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.
    Khan KN; Fujishita A; Koshiba A; Ogawa K; Mori T; Ogi H; Itoh K; Teramukai S; Kitawaki J
    PLoS One; 2020; 15(11):e0242246. PubMed ID: 33186388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.
    Mozzachio K; Moore AB; Kissling GE; Dixon D
    Toxicol Pathol; 2016 Apr; 44(3):450-7. PubMed ID: 26692562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and progesterone receptor content of enucleated uterine myomata after luteinizing hormone-releasing hormone. Analogue depot therapy.
    Cirkel U; Ochs H; Roehl A; Schneider HP
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):328-32. PubMed ID: 8160541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors.
    Zullo F; Pellicano M; De Stefano R; Zupi E; Mastrantonio P
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):108-12. PubMed ID: 9465812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.
    Friedman AJ; Harrison-Atlas D; Barbieri RL; Benacerraf B; Gleason R; Schiff I
    Fertil Steril; 1989 Feb; 51(2):251-6. PubMed ID: 2492232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
    Cheng YM; Chou CY; Huang SC; Lin HC
    BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
    Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions.
    Englund K; Lindblom B; Carlström K; Gustavsson I; Sjöblom P; Blanck A
    Mol Hum Reprod; 2000 Oct; 6(10):915-20. PubMed ID: 11006320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
    Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study.
    Cirkel U; Ochs H; Schneider HP; Mettler L; Mayer-Eichberger D; Schindler AE; Bühler K; Winkler U; Zahradnik HP; Künzig HJ
    Clin Ther; 1992; 14 Suppl A():37-50. PubMed ID: 1606593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo.
    Friedman AJ; Rein MS; Pandian MR; Barbieri RL
    Fertil Steril; 1990 Feb; 53(2):250-3. PubMed ID: 2105242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
    Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
    Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metachromasia of the endocervical epithelium in women treated with gonadotropin releasing hormone agonist.
    Morimura M; Ishiko O; Honda KI; Sumi T; Kawamura N; Wakasa K; Haba T; Ogita S
    Int J Mol Med; 2001 Sep; 8(3):319-21. PubMed ID: 11494062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.